| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.31 | 0.08 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.08 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.08 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.09 |